1064 results found | searching for "pharma"

• 
• Vetson Healthcare is monopoly based Veterinary PCD Pharma Franchise Company https://vetsonhealthcare.com/top-veterinary-pcd-companies-in-india/

  by vetsonhealthcare,  General Health Care 

  0 reply
• 
• Driving Efficiency and Innovation: Exploring the Single Use Bioprocessing Market https://www.marketsandmarkets.com/Market-Reports/single-use-bioprocessing-market-231651297.html The global single-use bioprocessing market is expected to reach USD 20.8 billion by 2026 from USD 8.2 billion in 2021, at a CAGR of 20.5% during the forecast period. The growth in this market is attributed to the increasing demand for low-cost biopharmaceuticals, as single-use bioprocessing systems play a significant role in reducing the initial investments and R&D costs involved in the manufacturing process of biologics. Moreover, the deployment of single-use bioprocessing systems increases the productivity of manufacturing processes as a result of reductions in cost and complexity of automation, and elimination of the need for change-over cleaning/validation between consecutive operations. However, issues such as plastic waste, extractability and leachability of the materials used in bioprocessing are expected to restrict the growth of this market.

  by Healthcare_medical,  Health 

  0 reply
• 
• https://www.hzfoodic.com/news/caffeic-acid-pharmaceutical-indu/ Conducting appropriate testing, and ensuring compliance with relevant standards and regulations,we can determine if caffeic acid meets the requirements of the pharmaceutical industry for your specific application. [more]

  by wen412710,  Medicine 

  0 reply
• 
• Shared Services Market by Function – Global Opportunities & Forecast, 2020-2027 - 5 The Shared Services Market is projected to foresee a substantial growth over the forecast period due to increasing emphasis on decreasing the overall production cost and enhancing the quality of the services delivered. The rapidly rising demand for economical treatment modalities and redesigning the conventional pharmaceutical research and development model is likely to raise the Shared Services Market size. For more info: http://jobhop.co.uk/blog/17095/shared-services-market-by-function--global-opportunities--forecast-2020-2027 [more]

  by MubazGmiseo,  Business & Finance 

  0 reply
• 
• Lactic Acid Market Research Report Size, Growth & Global Forecast – 1 The factors driving the growth of Lactic Acid Market includes increasing application of lactic acid across end-use industries such as pharmaceuticals and food and beverages, rising focus on reducing carbon emissions, growing use of lactic acids in skincare products and cosmetic therapies and improvements in the living standards. For more info: http://jobhop.co.uk/blog/17095/lactic-acid-market-research-report-size-growth--global-forecast--2022-2029 [more]

  by MubazGmi,  Business & Finance 

  0 reply
• 
• CAR-T Cell Therapy market Professional Survey Report by 2035 As the six approved CAR-T cell therapies, including Breyanzi®, Abecma™ and CARVYKTI™ are poised to achieve blockbuster status, along with a promising development pipeline, the field of CAR-T cell therapies has gained significant traction Roots Analysis is pleased to announce the publication of its recent study, titled, “Global CAR-T Cell Therapy Market (4th Edition), 2022-2035.” The study features an in-depth analysis of key drivers and trends related to this domain. Amongst other elements, the report includes:  A detailed assessment of the current market landscape of CAR-T-cell therapies.  An analysis of key insights derived from the study featuring a competitive analysis, highlighting the popular target antigens related to hematological malignancies and solid tumors.  A detailed analysis of completed, ongoing and planned clinical studies related to CAR-T cell therapies.  An insightful analysis highlighting the key opinion leaders (KOLs) in this domain featuring an analysis of the various principal investigators of clinical trials related to CAR-T cell therapies.  Elaborate profiles of marketed and mid- to late-stage clinical products (phase I/II or above).  An analysis of various type of partnership that have been inked between several stakeholders in the domain of CAR-T-cell therapies.  An analysis of the investments that have been made into companies that have proprietary CAR-T cell-based products / technologies.  An in-depth analysis of patents related to CAR-T cell therapies, filed / granted till 2022.  A case study on manufacturing cell therapy products, highlighting the key challenges, and a detailed list of contract service providers and in-house manufacturers involved in this space.  An elaborate discussion on various factors that form the basis for the pricing of cell-based therapies.  A review of the key promotional strategies being adopted by the developers of the approved CAR-T cell therapies.  Elaborate profiles of the several leading players in the domain of CAR-T cell therapies. A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below):  Target Indication(s)  Non-Hodgkin’s Lymphoma  Multiple Myeloma  Acute Lymphoblastic Leukemia  Chronic Lymphocytic Leukemia  Hodgkin’s Lymphoma  Acute Myeloid Leukemia  Ovarian Cancer  Generalized Myasthenia Gravis (MG)  Renal Cell Carcinoma  Target Antigen  CD19  BCMA  CD19/22  Others  Key Geographical Regions  North America  Europe  Asia Pacific  Latin America  Middle East and North Africa  Rest of the World Transcripts of interviews held with the following senior level representatives of stakeholder companies:  Troels Jordansen (Chief Executive Officer, Glycostem Therapeutics)  Wei (William) Cao (Chief Executive Officer, Gracell Biotechnologies)  Miguel Forte (Chief Operating Officer, TxCell)  Adrian Bot (Vice President, Scientific Affairs, Kite Pharma)  Vincent Brichard (Vice President, Immuno-Oncology, Celyad)  Brian Dattilo (Manager of Business Development, Waisman Biomanufacturing)  Aino Kalervo (Former Competitive Intelligence Manager, Strategy & Business Development, Theravectys)  Xian-Bao Zhan (Professor of Medicine and Director, Department of Oncology, Changhai Hospital)  Enkhtsetseg Purev (Assistant Professor of Medicine, University of Colorado) The research includes profiles of key players (listed below); each profile features a brief overview of the company, details related to its financial information (if available), details about CAR-T-cell based product(s), such as information on type of therapy and current development status, information on technology portfolio (if available), recent developments related to CAR-T cell immunotherapies and manufacturing capabilities of the players.  Autolus  bluebird Bio  Bristol Myers Squibb  Carsgen Therapeutics  Cellectis  Cellular Biomedicine Group  Gilead Sciences  Innovative Cellular Therapeutics  Kuur Therapeutics  Noile-Immune Biotech  Novartis  Shanghai GeneChem  Sinobioway Cell Therapy  Takara Bio  Wellington Zhaotai Therapies Get more details on the CAR-T Cell Therapy Market report https://www.rootsanalysis.com/reports/view_document/car-t-therapies-market/269.html You may also be interested in the following titles: DNA Encoded Libraries Quantum Computing in Drug Discovery Services Market You may also like to learn what our experts are sharing in Roots educational series: mRNA Synthesis: Manufacturing Process of Modern Revolutionary Molecule TIL Therapies: A New Paradigm in Cancer Treatment About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #CARTcelltherapyMarket #CARTcelltherapyMarket Size #CARTcellth0erapyMarketGrowth #CARTcelltherapies #ChimericAntigenReceptor

  by jameshebrew,  Health 

  0 reply
• 
• Machine Vision Market Size, Trends, Growth | Forecast 2027 The Machine Vision Market is expected to grow at a robust CAGR during the forecast period (2020-2027). The factors driving the growth of Machine Vision Market includes growing demand for vision guided robotic systems in end-use industries such as pharmaceutical, automotive, packaging and food & beverage and emerging need for quality inspection and automation. More Info, Click to Access Complete Report – https://dailygram.com/blog/1146616/machine-vision-market-size-trends-growth-forecast-2027/ [more]

  by arif11,  Business & Finance 

  0 reply
• 
• Ampoules Market Growth, Forecast 2021-2028 The Ampoules Market is anticipated to grow at a significant CAGR during the forecast period (2021-2028). The factors driving the growth of Ampoules Market includes increasing use of ampoules in the end-use industries such as Food & Beverage, and Pharmaceutical and rise in the number of chronic diseases such as Diabetes and high Blood Pressure around the world. More Info, Click to Access Complete Report – https://dailygram.com/blog/1161819/ampoules-market-growth-forecast-2021-2028/ [more]

  by arif11,  Business & Finance 

  0 reply
• 
• CMOs are exploring the potential of mammalian cell culture production amidst soaring demand for biopharmaceutical contract manufacturing services. Incumbents, such as Charles River and Lonza have furthered investments in mammalian cells. To illustrate, in May 2021, Lonza announced pouring USD 936 million to bolster the footprint of mammalian drug substance manufacturing sites in the U.S. and Switzerland. Biopharmaceutical firms are responding to the demand for outsourced services with bullish investments in research activities. For instance, in July 2022, Wuxi Biologics contemplated expanding its large-scale drug product & drug substance manufacturing capabilities and R&D in Singapore. Get your copy or request a free sample of the report @ https://www.grandviewresearch.com/market-trends/biopharmaceutical-cmo-cro-production-capacity-study [more]

  by latestmarketnews,  Business & Finance 

  0 reply
• 
• https://www.hzfoodic.com/news/purity-of-hydroxytyrosol/ Allow researchers and the medical industry to assess the purity of hydroxytyrosol and ensure its quality for various applications, such as pharmaceuticals, dietary supplements, or cosmetic formulations. [more]

  by wen412710,  Medicine 

  0 reply